The B-Cube Tests are geno-molecular analyses that use transcriptome based NGS data focused on disease-
linked markers and genetic pathways. A comprehensive report (approx. 20–30 pages) is provided, with an
optional Orthomolecular and Pharmacotranscriptomic Report available for clinicians. Any test record is
completely anonymous.
The BCube Tests currently available are:
• BCube Onco
For those who have a family history of cancer, have been diagnosed with cancer, are survivors of cancer, according more detailed information than the HrC screening test. The data can help clinicians understand the functioning of the cells that cause cancer. Results can help monitor treatment efficacy and also to provide cancer patients to early treatment direction.
• BCube Diabetes
For diabetic and pre-diabetic patients to understand their condition.
• BCube Cardiac
For patients who have known cardiovascular issues, and also for those without a current diagnosis who have a family history of cardiovascular disease, including Alzheimer's, Parkinson's, and Huntington's Disease.
• BCube Neuro
This test evaluates the risk/status of neurodegenerative diseases, including Alzheimer's, Parkinson's, and Huntington's Disease.